Investment in Potential

2019-09-25T17:23:11+00:00

CroiValve

CroíValve has developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation.

2019-09-25T17:24:24+00:00

Deciphex

Deciphex is developing digital pathology software applications, for clinical and toxicologic pathology, that improve productivity and help pathologists focus on the critical content.

2019-09-25T17:24:59+00:00

Longboat Clinical

Longboat Clinical - In the complex world of clinical development, Longboat's cloud-based site and patient engagement platform empowers clinical trial site staff and patients to do the right thing at the right time, from patient recruitment through to study closeout.

2018-07-31T16:11:37+00:00

AventaMed

AventaMed develops innovative medical devices which simplify surgery, allowing procedures to move out of the Operating Room and into new sites of service, such as the clinic or doctor’s office.

2018-07-31T16:12:16+00:00

Nexvet

Nexvet, a biologic therapeutics company, develop a pipeline of monoclonal antibody (mAb) therapies for companion animals in pain and other therapeutic areas.

If you are interested in becoming an Investor or seeking investment, then please contact us.